These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 18836734)
1. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture. Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734 [TBL] [Abstract][Full Text] [Related]
2. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Sone J; Tanaka F; Koike H; Inukai A; Katsuno M; Yoshida M; Watanabe H; Sobue G Neurology; 2011 Apr; 76(16):1372-6. PubMed ID: 21411744 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509 [TBL] [Abstract][Full Text] [Related]
4. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains. Villagra NT; Navascues J; Casafont I; Val-Bernal JF; Lafarga M; Berciano MT Neurobiol Dis; 2006 Jan; 21(1):181-93. PubMed ID: 16125395 [TBL] [Abstract][Full Text] [Related]
5. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child. McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647 [TBL] [Abstract][Full Text] [Related]
6. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis. Liu Y; Mimuro M; Yoshida M; Hashizume Y; Niwa H; Miyao S; Ujihira N; Akatsu H Acta Neuropathol; 2008 Dec; 116(6):615-23. PubMed ID: 18923837 [TBL] [Abstract][Full Text] [Related]
7. SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Pountney DL; Huang Y; Burns RJ; Haan E; Thompson PD; Blumbergs PC; Gai WP Exp Neurol; 2003 Nov; 184(1):436-46. PubMed ID: 14637113 [TBL] [Abstract][Full Text] [Related]
8. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Pountney DL; Chegini F; Shen X; Blumbergs PC; Gai WP Neurosci Lett; 2005 Jun 10-17; 381(1-2):74-9. PubMed ID: 15882793 [TBL] [Abstract][Full Text] [Related]
9. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376 [TBL] [Abstract][Full Text] [Related]
10. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1. Umahara T; Uchihara T; Yagishita S; Nakamura A; Tsuchiya K; Iwamoto T Neurosci Lett; 2007 Mar; 414(2):130-5. PubMed ID: 17224237 [TBL] [Abstract][Full Text] [Related]
11. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress. Woulfe JM Neuropathol Appl Neurobiol; 2007 Feb; 33(1):2-42. PubMed ID: 17239006 [TBL] [Abstract][Full Text] [Related]
13. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases. Uchihara T; Tanaka J; Funata N; Arai K; Hattori T Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220 [TBL] [Abstract][Full Text] [Related]
14. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134 [TBL] [Abstract][Full Text] [Related]
15. A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Nishie M; Mori F; Yoshimoto M; Takahashi H; Wakabayashi K Neuropathol Appl Neurobiol; 2004 Oct; 30(5):546-54. PubMed ID: 15488031 [TBL] [Abstract][Full Text] [Related]
16. Incipient intranuclear inclusion body disease in a 78-year-old woman. Mori F; Miki Y; Tanji K; Ogura E; Yagihashi N; Jensen PH; Wakabayashi K Neuropathology; 2011 Apr; 31(2):188-93. PubMed ID: 20667015 [TBL] [Abstract][Full Text] [Related]
17. SUMO on the road to neurodegeneration. Dorval V; Fraser PE Biochim Biophys Acta; 2007 Jun; 1773(6):694-706. PubMed ID: 17475350 [TBL] [Abstract][Full Text] [Related]
18. Neuronal intranuclear inclusion disease in a horse. Pumarola M; Vidal E; Trens JM; SerafĂn A; Marquez M; Ferrer I Acta Neuropathol; 2005 Aug; 110(2):191-5. PubMed ID: 15971054 [TBL] [Abstract][Full Text] [Related]
19. Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Mori F; Tanji K; Odagiri S; Toyoshima Y; Yoshida M; Ikeda T; Sasaki H; Kakita A; Takahashi H; Wakabayashi K Acta Neuropathol; 2012 Jul; 124(1):149-51. PubMed ID: 22661321 [No Abstract] [Full Text] [Related]